This inventor holds 13 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Tumor Treatment Technologies. Top assignee: Novocure Gmbh. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Beer Sheva, IL (2022 - 2024)
- Haifa, IL (2024)
- Be'er Sheva, IL (2024)
Company Filing History:
Years Active: 2022-2026
Areas of Expertise:
Title: Michael Shtotland: Innovator in Tumor Treating Fields Technology
Introduction: Michael Shtotland, a talented inventor based in Be'er Sheva, Israel, has made significant contributions to the field of medical technology. He is recognized for his innovative approach in the treatment of tumors, specifically through his development of a treatment assembly designed for providing tumor treating fields to animal test subjects.
Latest Patents: Michael holds one patent titled “Treatment assembly for providing tumor treating fields to animal test subjects.” This invention features an intricate design with an inner layer that has multiple openings allowing the inclusion of various plates. The treatment assembly also comprises treatment circuitry with a cable that connects electrical leads to electrode plates, enabling an effective therapeutic approach for tumor treatment.
Career Highlights: Michael is associated with Novocure GmbH, a company that specializes in cancer treatment technologies. His work focuses on advancing non-invasive treatment alternatives, showcasing his dedication to innovative healthcare solutions.
Collaborations: Throughout his career, Michael has collaborated with notable colleagues, including Mijal Munster and Yoram Wasserman, whose efforts in research and development complement his inventive initiatives.
Conclusion: Michael Shtotland stands out as a promising inventor whose work in tumor treating fields reflects a commitment to advancing medical technology. His contributions are invaluable, and they highlight the importance of innovation in improving treatment outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
